Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-46-7
Name of the chemical
Distillates (petroleum), hydrotreated middle
Concentration
15.0000-40.0000
EC/CAS
64741-86-2
Name of the chemical
Distillates (petroleum), sweetened middle
Concentration
10.0000-30.0000
General Information
Version
1 . 2
Revision date
2014-01-14
Product name
Safety (EHS) Phone
Manufacturer Name
INX International Ink Co
Emergency telephone
800.535.5053
Icons in SDS
Company Information
company name
INX International Ink Co
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS@inxintl.com
Section 2
SECTION 2: Hazards identification
OSHA HCS Classification
Irritating material Form This is a Product Line MSDS (PLDS) relevant to multiple but similar printing ink formulations. Accordingly, physical data values are given as ranges representative of the base colors for this product line. Physical data for a specific formulation may be derived from the CPDS (Certified Product Data Sheet). Customers may also request an itemized report of regulated constituents based on sales history for a given period. Emergency overview WARNING CAUSES SKIN IRRITATION. PROLONGED OR REPEATED CONTACT MAY DRY SKIN AND CAUSE IRRITATION. Irritating to skin. Defatting to the skin. Avoid contact with eyes. Avoid breathing vapor or mist. Avoid contact with skin and clothing. Routes of entry skin Inhalation eyes ingestion
Potential Acute Health Effects
Eye contact May cause eye irritation. Skin contact Irritating to skin. inhalation No known significant effects or critical hazards. ingestion No known significant effects or critical hazards. Potential chronic health effects Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects :No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Over-exposure signs/symptoms Eye/face No specific data. skin Adverse symptoms may include the following: irritation redness dryness cracking inhalation No specific data. ingestion No specific data. Medical conditions aggravated by over-exposure None known.